Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 24523595)

1.

Molecular variants and mutations in medulloblastoma.

Schroeder K, Gururangan S.

Pharmgenomics Pers Med. 2014 Feb 4;7:43-51. doi: 10.2147/PGPM.S38698. eCollection 2014. Review.

2.

The therapy of infantile malignant brain tumors: current status?

Kalifa C, Grill J.

J Neurooncol. 2005 Dec;75(3):279-85. Review.

PMID:
16195802
3.

[Childhood medulloblastoma].

Yazigi-Rivard L, Masserot C, Lachenaud J, Diebold-Pressac I, Aprahamian A, Avran D, Doz F.

Arch Pediatr. 2008 Dec;15(12):1794-804. doi: 10.1016/j.arcped.2008.09.021. Epub 2008 Nov 7. Review. French.

PMID:
18995998
4.

Medulloblastoma molecular dissection: the way toward targeted therapy.

Remke M, Ramaswamy V, Taylor MD.

Curr Opin Oncol. 2013 Nov;25(6):674-81. doi: 10.1097/CCO.0000000000000008. Review.

PMID:
24076581
5.
6.

Genetics of medulloblastoma: clues for novel therapies.

Onvani S, Etame AB, Smith CA, Rutka JT.

Expert Rev Neurother. 2010 May;10(5):811-23. doi: 10.1586/ern.10.31. Review.

PMID:
20420498
7.

Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.

Pollack IF.

J Neurosurg Pediatr. 2011 Aug;8(2):135-48. doi: 10.3171/2011.5.PEDS1178. Review.

PMID:
21806354
8.

Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.

Reddick WE, Russell JM, Glass JO, Xiong X, Mulhern RK, Langston JW, Merchant TE, Kun LE, Gajjar A.

Magn Reson Imaging. 2000 Sep;18(7):787-93.

PMID:
11027871
9.

[Medulloblastomas: review].

Taillandier L, Blonski M, Carrie C, Bernier V, Bonnetain F, Bourdeaut F, Thomas IC, Chastagner P, Dhermain F, Doz F, Frappaz D, Grill J, Guillevin R, Idbaih A, Jouvet A, Kerr C, Donadey FL, Padovani L, Pallud J, Sunyach MP.

Rev Neurol (Paris). 2011 May;167(5):431-48. doi: 10.1016/j.neurol.2011.01.014. Epub 2011 May 6. Review. French.

PMID:
21529869
10.

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

Remke M, Hielscher T, Korshunov A, Northcott PA, Bender S, Kool M, Westermann F, Benner A, Cin H, Ryzhova M, Sturm D, Witt H, Haag D, Toedt G, Wittmann A, Schöttler A, von Bueren AO, von Deimling A, Rutkowski S, Scheurlen W, Kulozik AE, Taylor MD, Lichter P, Pfister SM.

J Clin Oncol. 2011 Oct 10;29(29):3852-61. doi: 10.1200/JCO.2011.36.2798. Epub 2011 Sep 12.

11.

Review of the prognostic factors in medulloblastoma of children and adults.

Brandes AA, Paris MK.

Crit Rev Oncol Hematol. 2004 May;50(2):121-8. Review.

PMID:
15157661
12.

Medulloblastoma: what is the role of molecular genetics?

Entz-Werle N, Carli ED, Ducassou S, Legrain M, Grill J, Dufour C.

Expert Rev Anticancer Ther. 2008 Jul;8(7):1169-81. doi: 10.1586/14737140.8.7.1169. Review.

PMID:
18588461
13.

Recent developments and current concepts in medulloblastoma.

Gerber NU, Mynarek M, von Hoff K, Friedrich C, Resch A, Rutkowski S.

Cancer Treat Rev. 2014 Apr;40(3):356-65. doi: 10.1016/j.ctrv.2013.11.010. Epub 2013 Dec 6. Review.

PMID:
24389035
14.

Molecular diagnostics of CNS embryonal tumors.

Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD.

Acta Neuropathol. 2010 Nov;120(5):553-66. doi: 10.1007/s00401-010-0751-5. Epub 2010 Sep 30. Review.

PMID:
20882288
15.

Update on molecular and genetic alterations in adult medulloblastoma.

Kool M, Korshunov A, Pfister SM.

Memo. 2012 Sep;5(3):228-232. Epub 2012 Jul 20.

16.

Medulloblastoma comprises four distinct molecular variants.

Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD.

J Clin Oncol. 2011 Apr 10;29(11):1408-14. doi: 10.1200/JCO.2009.27.4324. Epub 2010 Sep 7.

17.

Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET).

De Braganca KC, Packer RJ.

Curr Treat Options Neurol. 2013 Oct;15(5):593-606. doi: 10.1007/s11940-013-0255-4.

PMID:
23979905
18.

Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors.

Adamski J, Ramaswamy V, Huang A, Bouffet E.

F1000Prime Rep. 2014 Jul 8;6:56. doi: 10.12703/P6-56. eCollection 2014. Review.

19.

The clinical implications of medulloblastoma subgroups.

Northcott PA, Korshunov A, Pfister SM, Taylor MD.

Nat Rev Neurol. 2012 May 8;8(6):340-51. doi: 10.1038/nrneurol.2012.78. Review.

PMID:
22565209
20.

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.

Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD, Radlwimmer B, Scheurlen W, Lichter P, Korshunov A.

J Clin Oncol. 2009 Apr 1;27(10):1627-36. doi: 10.1200/JCO.2008.17.9432. Epub 2009 Mar 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk